Pharmacogenetic testing revisited: 5′nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19

Pharmacogenetic testing revisited: 5′nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19

Jens Borggaard Larsen, Jan Borg Rasmussen Laboratory Unit, Danish Epilepsy Centre, Filadelfia, Dianalund, Denmark Abstract: Due to their involvement in the metabolization of commonly prescribed psychopharmaceutical drugs, the cytochrome oxidase genes CYP2D6 and CYP2C19 are extensive targets...

Full description

Bibliographic Details
Main Authors: Larsen JB, Rasmussen JB
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Genotyping
5'nuclease assay
Drug metabolization
CYP2C19
CYP2D6
Pharmocogenetics
Online Access:https://www.dovepress.com/pharmacogenetic-testing-revisited-5primenuclease-real-time-polymerase--peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/pharmacogenetic-testing-revisited-5primenuclease-real-time-polymerase--peer-reviewed-article-PGPM

Similar Items